Cigna drops coverage of GLP-1 obesity drugs for its own employees: What’s the future of weight-loss treatment

Starting July 2026, Cigna is drawing a line in the sand by discontinuing coverage for popular weight-loss medications like Wegovy and Zepbound for its employees. Citing rising expenses and available…

Continue ReadingCigna drops coverage of GLP-1 obesity drugs for its own employees: What’s the future of weight-loss treatment